| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |